Physician profile
Lance Henry
NPI 1679682520
$39,434.76
in general payments reported to CMS, 2019-2025
16 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $14.38 · 2021: $5,410 · 2022: $16K · 2023: $10K · 2024: $7,709 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,262.23 |
| Food and Beverage | $680.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $20,455.30 | 2019-2022 | |
| Abbvie INC. | $17,833.10 | 2019-2025 | |
| Genzyme Corporation | $315.41 | 2019-2025 | |
| Pfizer INC. | $207.30 | 2019-2022 | |
| Lilly USA, LLC | $176.69 | 2019-2024 | Olumiant, Taltz |
| Novartis Pharmaceuticals Corporation | $138.16 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $78.46 | 2022-2023 | Winlevi, Absorica Ld, Ilumya |
| Galderma Laboratories, L.P. | $58.70 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $38.76 | 2021-2022 | |
| Janssen Biotech, INC. | $27.57 | 2019-2022 | |
| Almirall LLC | $23.76 | 2021 | |
| Krystal Biotech INC | $22.03 | 2024 | Vyjuvek |
| Amgen INC. | $20.26 | 2025 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $15.22 | 2024 | Sotyktu |
| Incyte Corporation | $12.64 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.